Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine vs Desloratadine in Histamine-Induced Wheal and Flare
NCT00637585Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fexofenadine in allergic rhinitis (AR) (3 arms), sponsored by Sanofi. Primary endpoint: Size of change in summation skin flares from baseline at 24 hours. Started Dec 2002; status: completed.
02
Drugs
fexofenadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00637585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637585.